THE OFFICIAL NEWS SOURCE OF ACR CONVERGENCE 2022 • NOVEMBER 10-14


  • Choose an in-person or virtual experience for ACR Convergence 2022

    Choose an in-person or virtual experience for ACR Convergence 2022

    Registration is open for this year’s premier rheumatology experience, taking place November 10-14 in Philadelphia. Don’t miss special pricing for early registration, available through August 30, for in-person and virtual participation. READ MORE

  • Planning Committee Chair Dr. Sharon Kolasinski previews ACR Convergence 2022

    Planning Committee Chair Dr. Sharon Kolasinski previews ACR Convergence 2022

    ACR Convergence 2022 will offer the most comprehensive presentation of basic science, clinical research, and advances in clinical care in rheumatology, with the choice of in-person or virtual registration. Annual Meeting Planning Committee Chair Sharon L. Kolasinski, MD, FACR, provides a first look at what attendees can expect from the meeting “where rheumatology meets.” READ MORE

  • New findings inform new approaches to Sjögren’s

    New findings inform new approaches to Sjögren’s

    At ACR Convergence 2021, a panel of experts — A. Darise Farris, PhD, Blake M. Warner, DDS, PhD, MPH, and Xavier Mariette, MD, PhD — explored the dynamics of the treatment of Sjögren’s syndrome, including epigenetic links between immune and salivary gland dysfunction and targeted therapy. READ MORE

  • Age is a key factor in effective immune response

    Age is a key factor in effective immune response

    Cornelia M. Weyand, MD, PhD, explored the mechanisms and sequelae of aging immune systems during ACR Convergence 2021. For even the healthiest humans, the age-related risk of cancer, cardiovascular disease, infectious disease, and neurodegenerative disease comes back to one factor: older immune systems are less flexible, less responsive, and less effective. READ MORE

  • Some chronic pain can be managed without drugs

    Some chronic pain can be managed without drugs

    Rinie Geenen, PhD, discussed pain management regimens in rheumatic and musculoskeletal diseases, Christine Stamatos, DNP, ANP-C, discussed targeted pharmacologic and nonpharmacologic therapies for chronic pain, and Afton Hassett, PysD, outlined behavioral interventions as pain management. READ MORE

  • Post-COVID-19 syndromes can affect several systems

    Post-COVID-19 syndromes can affect several systems

    In an ACR Convergence symposium, Anthony L. Komaroff, MD, discussed neurological syndromes associated with long COVID, Matthew Ehrlich, MD, discussed the mental health impact of the pandemic, and George A. Alba, MD, discussed the pulmonary sequelae of COVID-19. READ MORE

  • Expanded provider reach, patient time savings boost popularity of telemedicine

    Expanded provider reach, patient time savings boost popularity of telemedicine

    Nearly 90% of all physicians had used telehealth by the end of 2020, about half of them for the first time. Jesse D. Overbay, JD, explained this pandemic-induced shift in medicine and its lasting impact on clinical practice. READ MORE

  • Effective communication begins with RHEUM

    Effective communication begins with RHEUM

    Communications expert Janet Zeide, JD, outlined five principles for engaging presentations, meetings, papers, emails, and more for clinicians, investigators, and educators. READ MORE

  • 170-year-old report promoting racial discrimination in healthcare continues to negatively affect outcomes

    170-year-old report promoting racial discrimination in healthcare continues to negatively affect outcomes

    Ashira D. Blazer, MD, discussed the origins and realities of modern-day racism and racial disparities in healthcare, including how to navigate negative behaviors such as microaggression and gaslighting. READ MORE

  • Rheumatic diseases elevate cardiovascular disease risks

    Rheumatic diseases elevate cardiovascular disease risks

    For the general population, lower cholesterol, particularly lower LDL cholesterol, is good news for cardiovascular risk. Christina Charles-Schoeman, MD, MS, and Jorge Plutzky, MD, explained its impact on patients with rheumatoid arthritis and other rheumatic diseases. READ MORE